MYRIAD GENETICS, INC. Proceeds from Sale of Intangible Assets
MYRIAD GENETICS, INC. (MYGN) reported Proceeds from Sale of Intangible Assets of $300.00 thousand for the 12-month period ending 2010-06-30, per its 10-K filed 2012-08-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfIntangibleAssets · last filed 2012-08-15
- MYRIAD GENETICS, INC. proceeds from sale of intangible assets for the quarter ending 2010-06-30 was $0.00.
- MYRIAD GENETICS, INC. proceeds from sale of intangible assets for fiscal 2010 was $300.00K.
| Period end | Proceeds from Sale of Intangible Assets 3 month | Proceeds from Sale of Intangible Assets 9 month | Proceeds from Sale of Intangible Assets 12 month |
|---|---|---|---|
| 2010-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-15 | $300.00K 10-K · filed 2012-08-15 | |
| 2010-03-31 | $300.00K 10-Q · filed 2011-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |